Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently sold shares of Teleflex Incorporated NYSE: TFX. In a filing disclosed on March 27th, the Representative disclosed that they had sold between $1,001 and $15,000 in Teleflex stock on February 25th. The trade occurred in the Representative's "JP MORGAN BROKERAGE ACCOUNT" account.
Representative Robert Bresnahan, Jr. also recently made the following trade(s):
- Purchased $1,001 - $15,000 in shares of Intuit NASDAQ: INTU on 3/7/2025.
- Sold $1,001 - $15,000 in shares of Tesla NASDAQ: TSLA on 3/6/2025.
- Purchased $1,001 - $15,000 in shares of SEA NYSE: SE on 3/5/2025.
- Sold $1,001 - $15,000 in shares of Credo Technology Group NASDAQ: CRDO on 3/4/2025.
- Purchased $1,001 - $15,000 in shares of Meta Platforms NASDAQ: META on 3/4/2025.
- Purchased $1,001 - $15,000 in shares of Twilio NYSE: TWLO on 3/4/2025.
- Sold $15,001 - $50,000 in shares of Alibaba Group NYSE: BABA on 3/4/2025.
- Purchased $1,001 - $15,000 in shares of Zoom Video Communications NASDAQ: ZM on 3/4/2025.
- Purchased $1,001 - $15,000 in shares of Intel NASDAQ: INTC on 3/3/2025.
- Purchased $1,001 - $15,000 in shares of Snowflake NYSE: SNOW on 3/3/2025.
Teleflex Trading Up 0.6 %
Shares of TFX traded up $0.79 during trading hours on Wednesday, hitting $141.09. 168,158 shares of the stock traded hands, compared to its average volume of 582,667. The firm has a market capitalization of $6.54 billion, a PE ratio of 28.05, a price-to-earnings-growth ratio of 1.73 and a beta of 1.21. The business has a fifty day moving average of $157.48 and a 200-day moving average of $188.50. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 1-year low of $128.55 and a 1-year high of $249.91.
Teleflex (NYSE:TFX - Get Free Report) last announced its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, topping analysts' consensus estimates of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company had revenue of $795.40 million for the quarter, compared to analysts' expectations of $813.24 million. Analysts expect that Teleflex Incorporated will post 13.98 EPS for the current year.
Teleflex Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were paid a $0.34 dividend. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 annualized dividend and a dividend yield of 0.96%. Teleflex's dividend payout ratio (DPR) is currently 95.77%.
Institutional Investors Weigh In On Teleflex
Institutional investors have recently made changes to their positions in the stock. HighTower Advisors LLC raised its stake in Teleflex by 1.7% during the third quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company's stock worth $986,000 after acquiring an additional 66 shares in the last quarter. CANADA LIFE ASSURANCE Co lifted its stake in Teleflex by 0.4% in the 4th quarter. CANADA LIFE ASSURANCE Co now owns 20,320 shares of the medical technology company's stock valued at $3,614,000 after purchasing an additional 74 shares during the last quarter. Hengehold Capital Management LLC boosted its position in Teleflex by 7.3% in the fourth quarter. Hengehold Capital Management LLC now owns 1,289 shares of the medical technology company's stock valued at $229,000 after buying an additional 88 shares in the last quarter. Exchange Traded Concepts LLC grew its stake in shares of Teleflex by 38.2% during the fourth quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock worth $61,000 after buying an additional 94 shares during the last quarter. Finally, MassMutual Private Wealth & Trust FSB increased its holdings in shares of Teleflex by 103.1% during the first quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company's stock worth $27,000 after buying an additional 100 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
Several research firms have recently weighed in on TFX. Citizens Jmp cut Teleflex from an "outperform" rating to a "market perform" rating in a report on Thursday, February 27th. Truist Financial lowered their price objective on shares of Teleflex from $200.00 to $149.00 and set a "hold" rating for the company in a research report on Monday, March 3rd. Raymond James downgraded Teleflex from an "outperform" rating to a "market perform" rating in a research note on Friday, February 28th. Piper Sandler reissued a "neutral" rating and issued a $140.00 target price (down from $255.00) on shares of Teleflex in a research note on Friday, February 28th. Finally, Morgan Stanley cut their price target on shares of Teleflex from $275.00 to $191.00 and set an "overweight" rating for the company in a research note on Wednesday, March 5th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $182.63.
View Our Latest Research Report on TFX
About Representative Bresnahan
Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania's 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania's 8th Congressional District. He declared candidacy for the 2026 election.
Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.
About Teleflex
(
Get Free Report)
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
See Also
Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
